XML 15 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Cash flows from operating activities:    
Net loss $ (2,587,000) $ (22,445,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 160,000 261,000
Stock based compensation expense 132,000 298,000
(Recovery of) reserve for excess and slow-moving inventories 27,000 (71,000)
Bad debt expense 37,000 7,000
Amortization of debt discount and issue costs 10,011,000
Change in fair value of derivative 13,000 326,000
Non-cash accrued interest 10,373,000
Net change in operating assets and liabilities:    
Accounts receivable 258,000 155,000
Inventories 85,000 258,000
Prepaid expenses and other current assets (48,000) 43,000
Accounts payable 446,000 (832,000)
Accrued payroll and related expenses 44,000 (77,000)
Deferred revenue 6,000 (224,000)
Other current liabilities (53,000) (122,000)
Other noncurrent liabilities 30,000 30,000
Net cash used in operating activities (1,450,000) (2,009,000)
Net cash flows used in investing activities:    
Cash paid for business acquisition (1,000,000)
Capital expenditures (140,000) (154,000)
Net cash used in investing activities: (1,140,000) (154,000)
Cash flows from financing activities:    
Payments on capital lease obligations (17,000) (23,000)
Cash paid for taxes on vested restricted stock (52,000) (134,000)
Proceeds from long-term debt-related party 1,500,000
Proceeds from issuance of common stock, net 2,091,000
Net cash provided by financing activities 1,431,000 1,934,000
Effects of foreign currency rate changes on cash and cash equivalents 2,000
Net decrease in cash and cash equivalents (1,159,000) (227,000)
Cash and cash equivalents at beginning of period 3,623,000 5,835,000
Cash and cash equivalents at end of period 2,464,000 5,608,000
Supplemental non-cash financing and investing information:    
Common stock issued for payment of convertible debentures and interest 23,905,000
Subsidiary common stock issued for acquisition of net assets $ 2,499,000